CCL2 and head and neck cancer: RFX1 knockout led to decreased HDAC1 and SUV39H1 recruitment to the MCP1 promoter, increasing its expression [68], which on the other hand, promotes EMT and cell migration in MCF-7 and OML1 (human head and neck cancer cell line) [8, 69].